We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

92 hedge funds and large institutions have $15.3M invested in Zomedica Corp. in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

31% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 13

5% more funds holding

Funds holding: 88 → 92 (+4)

22% less capital invested

Capital invested by funds: $19.5M → $15.3M (-$4.24M)

Holders
92
Holders Change
+4
Holders Change %
+4.55%
% of All Funds
1.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
17
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$510K
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$46.9K
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$36K
4
Morgan Stanley
Morgan Stanley
New York
+$31.6K
5
MCC
Money Concepts Capital
Florida
+$31.2K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$182K
2
VF
Virtu Financial
New York
-$115K
3
Charles Schwab
Charles Schwab
California
-$73K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$46K
5
UBS Group
UBS Group
Switzerland
-$44K

ZOM Hedge Fund Activity: Q4 2022 in Review

92 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q4 2022, worth a combined $15.3M — down 22% from $19.5M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ZOM positions and 8 closed out — a net gain of 5 holders — while 17 added to existing stakes and 13 trimmed.

The largest buyer was Vanguard Group, adding an estimated $510K. The largest seller was Renaissance Technologies, cutting an estimated $182K.

  • 92 institutional investors held Zomedica Corp. (ZOM) as of Q4 2022, up from 88 in Q3 2022.
  • Funds reported $15.3M of Zomedica Corp. stock for Q4 2022, down 22% quarter-over-quarter.
  • 13 funds opened new Zomedica Corp. positions in Q4 2022 and 8 closed out, a net change of +5 holders.
  • The largest Zomedica Corp. buyer in Q4 2022 was Vanguard Group, an estimated $510K added.
  • The largest Zomedica Corp. seller in Q4 2022 was Renaissance Technologies, an estimated $182K sold.

Based on aggregated 13F filings for Q4 2022.